References
1. Eisen, GM, Baron, TH, Dominitz, JA, et al. Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc 2002; 55:775
2. Cancer therapy evaluation program: Common Terminology Criteria for Adverse Events (CTCAE)v4.0.[http://ctep.cancer.gov/protocolDevelopment/ electronic_applications/ctc.htm] (v4.03: June 14, 2010
4. Cotton PB, Lehman G, Vennes J et al: Endoscopio sphincterotomy complications and their management: an attemp at consensus. Gastorintest Endosc 1991;37:383-393
5. Katsinelos P, Lazaraki G, Chatzimavroudis G et al. Risk factors for therapeutic ERCP-related complications: an analysis of 2,715 cases performed by a single endoscopist. Ann Gastroenterol. 2014;27(1):65-72
6. Anderson MA, Fisher L, Jain R, et al. Complications of ERCP. Gastrointest Endosc 2012;75(3):467–73
7. Mergener K. Complications of endoscopic and radiologic investigation of biliary tract disorders. Curr Gastroenterol Rep 2011;13:173–81
8. Loperfido S, Angelini G, Benedetti G et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998;48:1–10
9. Glomsaker T, Hoff G, Kvaløy JT et al; Norwegian Gastronet ERCP Group. Patterns and predictive factors of complications after endoscopic retrograde cholangiopancreatography. Br J Surg. 2013 Feb;100(3):373-80. doi: 10.1002/bjs.8992. Epub 2012 Dec 6
10. Huibregtse K, Katon RM, Tytgat GN. Precut papillotomy via fine-needle knife papillotome: a safe and effective technique. Gastrointest Endosc 1986; 32: 403-405
11. Freeman ML. Complications of endoscopic retrograde cholangiopancreatography: avoidance and management. Gastrointest Endosc Clin N Am 2012;22:567–86
12. Jamry A. Comparative analysis of endoscopic precut conventional and needle knife sphincterotomy. World J Gastroenterol. 2013;19(14):2227-33. doi: 10.3748/wjg.v19.i14.2227
13. Balmadrid B, Kozarek R Prevention and management of adverse events of endoscopic retrograde cholangiopancreatography. Gastrointest Endosc Clin N Am. 2013 Apr;23(2):385-403. doi: 10.1016/j.giec.2012.12.007
14. Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996;335:909–18
15. Freeman ML. Adverse outcomes of ERCP. Gastrointest Endosc 2002;56:S273–8).33
16. Ferreira LE, Fatima J, Baron TH. Clinically significant delayed postsphincterotomybleeding: a twelve year single center experience. Minerva Gastroenterol Dietol 2007;53:215–2
17. Kapral C, Duller C,Wewalka F et al. Case volume and outcome of endoscopic retrograde cholangiopancreatography: results of a nationwide Austrian benchmarking project. Endoscopy 2008;40(8):625–30
18. Kim KH, Kim TN. Endoscopic papillary large balloon dilation in patients with periampullary diverticula. World J Gastroenterol 2013; 19(41): 7168-7176 Available from: URL: http://www.wjgnet. com/1007-9327/full/v19/i41/7168.htm DOI: http://dx.doi. org/10.3748/wjg.v19.i41.7168
19. Zippi M, Traversa G, Pica R et al. Efficacy and safety of endoscopic retrograde cholangiopancreatography (ERCP) performed in patients with Periampullary duodenal diverticula (PAD).Clin Ter. 2014 Jul-Aug;165(4):e291-4. doi: 10.7417/CT.2014.1745.
20. Park SJ, Kim JH, Hwang JC et al. Factors predictive of adverse events following endoscopic papillary large balloon dilation: results from a multicenter series. Dig Dis Sci. 2013 Apr;58(4):1100-9. doi: 10.1007/s10620-012-2494-8. Epub 2012 Dec 8
21. Tanaka Y, Sato K, Tsuchida H et al. A prospective randomized controlled study of endoscopic sphincterotomy with the endocut mode or conventional blended cut mode. Clin Gastroenterol. 2015 Feb;49(2):127-31. doi: 10.1097/MCG.0000000000000096
22. Yang XM, Hu B. Endoscopic sphincterotomy plus large-balloon dilation vs endoscopic sphincterotomy for choledocholithiasis: a meta-analysis. World J Gastroenterol. 2013 Dec 28;19(48):9453-60. doi: 10.3748/wjg.v19.i48.9453
23. Kim JH, Yang MJ, Hwang JC et al. Endoscopic papillary large balloon dilation for the removal of bile duct stones. World J Gastroenterol. 2013 Dec 14;19(46):8580-94. doi: 10.3748/wjg.v19.i46.8580
24. Baron TH, Harewood GC. Endoscopic balloon dilation of the biliary sphincter compared to endoscopic biliary sphincterotomy for removal of common bile duct stones during ERCP: a metaanalysis of randomized, controlled trials. Am J Gastroenterol 2004; 99:1455–1460
25. Weinberg B, Shindy W, Lo S. Endoscopic balloon sphincter dilation (sphincteroplasty) versus sphincterotomy for common bile duct stones. Cochrane Database Syst Rev 2006; 4:CD004890
26. Zhao HC, He L, Zhou DC et al. Meta-analysis comparison of endoscopic papillary balloon dilatation and endoscopic sphincteropapillotomy. World J Gastroenterol. 2013 Jun 28;19(24):3883-91. doi: 10.3748/wjg.v19.i24.3883
27. Liao WC, Tu YK, Wu MS et al. Balloon dilation with adequate duration is safer than sphincterotomy for extracting bile duct stones: a systematic review and meta-analyses. Clin Gastroenterol Hepatol.2012 Oct;10(10):1101-9. doi: 10.1016/j.cgh.2012.05.017. Epub 2012 May 27
28. Liu Y, Su P, Lin Y et al. Endoscopic sphincterotomy plus balloon dilation versus endoscopic sphincterotomy for choledocholithiasis: A meta-analysis. J Gastroenterol Hepatol. 2013 Jun;28(6):937-45. doi: 10.1111/jgh.12192
29. Feng Y, Zhu H, Chen X et al. Comparison of endoscopic papillary large balloon dilation and endoscopic sphincterotomy for retrieval of choledocholithiasis: a meta-analysis of randomized controlled trials. J Gastroenterol. 2012 Jun;47(6):655-63. doi: 10.1007/s00535-012-0528-9. Epub 2012 Feb 24
30. Liu Y, Su P, Lin S et al. Endoscopic papillary balloon dilatation versus endoscopic sphincterotomy in the treatment for choledocholithiasis: a meta-analysis. J Gastroenterol Hepatol.2012 Mar;27(3):464-71. doi: 10.1111/j.1440-1746.2011.06912.x
31. He L, Geng XP, Zhao HC et al. [Endoscopic papillary balloon dilatation vs. endoscopic sphincteropapillotomy for common bile duct stones: a meta analysis].[Article in Chinese]. Zhonghua Wai Ke Za Zhi. 2013 Jun 1;51(6):556-61
32. Jin PP, Cheng JF, Liu D et al. Endoscopic papillary large balloon dilation vs endoscopic sphincterotomy for retrieval of common bile duct stones: a meta-analysis. World J Gastroenterol. 2014 May 14;20(18):5548-56. doi: 10.3748/wjg.v20.i18.5548
33. Paspatis GA, Konstantinidis K, Tribonias G et al. Sixty versus thirty seconds papillary balloon dilation after sphincterotomy for the treatment of large bile duct stones: a randomized controlled trial. Dig Liver Dis. 2013 Apr;45(4):301-4. doi: 10.1016/j.dld.2012.10.015. Epub 2012 Nov 26
34. Liao WC, Lee CT, Chang CY et al. Randomized trial of 1-minute versus 5-minute endoscopic balloon dilation for extraction of bile duct stones. Gastrointest Endosc. 2010 Dec;72(6):1154-62. doi: 10.1016/j.gie.2010.07.009. Epub 2010 Sep 25
35. Tsai TJ, Lai KH, Lin CK et al. Role of endoscopic papillary balloon dilation in patients with recurrent bile duct stones after endoscopic sphincterotomy.J Chin Med Assoc. 2014 Sep 17. pii: S1726-4901(14)00208-1. doi: 10.1016/j.jcma.2014.08.004
36. Gurusamy K, Sahay SJ, Burroughs AK et al. Systematic review and meta-analysis of intraoperative versus preoperative endoscopi sphincterotomy in patients with gallbladder and suspected common bile duct stones. Br J Surg.2011 Jul;98(7):908-16. doi: 10.1002/bjs.7460. Epub 2011 Apr 7
37. Wang B, Guo Z, Liu Z et al. Preoperative versus intraoperative endoscopic sphincterotomy in patients with gallbladder and suspected common bile duct stones: system review and meta-analysis. Surg Endosc. 2013 Jul;27(7):2454-65. doi: 10.1007/s00464-012-2757-7. Epub 2013 Jan 26)
38. Hammerle CW, Haider S, Chung M et al. Endoscopic retrograde cholangiopancreatography complications in the era of cholangioscopy: is there an increased risk? Dig Liver Dis. 2012 Sep;44(9):754-8. doi: 10.1016/j.dld.2012.04.024. Epub 2012 Jun 21
39. Cui PJ, Yao J, Zhao YJ et al. Biliary stenting with or without sphincterotomy for malignant biliary obstruction: a meta-analysis. World J Gastroenterol. 2014 Oct 14;20(38):14033-9. doi: 10.3748/wjg.v20.i38.14033
40. Canena J, Liberato M, Horta D et al. Short-term stenting using fully covered self-expandable metal stents for treatment of refractory biliary leaks, postsphincterotomy bleeding, and perforations. Surg Endosc.2013 Jan;27(1):313-24. doi: 10.1007/s00464-012-2368-3. Epub 2012 Jul 18
41. Navaneethan U, Konjeti R, Venkatesh PGK et al. Early precut sphincterotomy and the risk of endoscopic retrograde colangiopancreatography related complications: An updated meta-analysis. World J Gastrointest Endosc 2014 May 16; 6(5): 200-208
42. Cennamo V, Fuccio L, Zagari RM et al. Can early precut implementation reduce endoscopic retrograde cholangiopancreatography-related complication risk? Meta-analysis of randomized controlled trials. Endoscopy. 2010 May;42(5):381-8. doi: 10.1055/s-0029-1243992. Epub 2010 Mar 19
43. Bruins Slot W, Schoeman MN, Disario JA et al. Needle-knife sphincterotomy as a precut procedure: a retrospective evaluation of efficacy and complications. Endoscopy 1996; 28: 334-339
44. Lin LF. Transpancreatic precut sphincterotomy for biliary access: the relation of sphincterotomy size to immediate success rate of biliary cannulation. Diagn Ther Endosc. 2014;2014:864082. doi: 10.1155/2014/864082. Epub 2014 Mar 10
45. Katsinelos P, Gkagkalis S, Chatzimavroudis G et al. Comparison of three types of precut technique to achieve common bile duct cannulation: a retrospective analysis of 274 cases. Dig Dis Sci.2012 Dec;57(12):3286-92. doi: 10.1007/s10620-012-2271-8. Epub 2012 Jun 20
46. Kubota K, Sato T, Kato S, Watanabe S et al. Needle-knife precut papillotomy with a small incision over a pancreatic stent improves the success rate and reduces the complication rate in difficult biliary cannulations. J Hepatobiliary Pancreat Sci. 2013 Mar;20(3):382-8. doi: 10.1007/s00534-012-0552-4
47. Ismail S, Marianne U, Heikki J et al. Endoscopic papillectomy, single-centre experience. Surg Endosc. 2014 Nov;28(11):3234-9. doi: 10.1007/s00464-014-3596-5. Epub 2014 Jun 14
48. De Palma GD. Endoscopic papillectomy: indications, techniques, and results. World J Gastroenterol. 2014 Feb 14;20(6):1537-43. doi: 10.3748/wjg.v20.i6.1537
49. Ito K, Fujita N, Noda Y et al. Impact of technical modification of endoscopic papillectomy for ampullary neoplasm on the occurrence of complications. Dig Endosc. 2012 Jan;24(1):30-5. doi: 10.1111/j.1443-1661.2011.01161.x. Epub 2011 Jun 1
50. Torres V, Martinez N, Lee G et al. How do we manage post-OLT redundant bile duct? World J Gastroenterol. 2013 Apr 28;19(16):2501-6. doi: 10.3748/wjg.v19.i16.2501
51. Ambrus RB, Svendsen LB, Hillingsø JG et al. Post-Endoscopic Retrograde Cholangiopancreaticography complications in liver transplanted patients, a single-center experience. Scand J Surg. 2014 Apr 15
52. Sanna C, Giordanino C, Giono I et al: Safety and efficacy of endoscopic retrograde cholangiopancreatography in patients with post-liver transplant biliary complications: results of a cohort study with long-term follow-up. Gut Liver 2011;5:328– 334
53. Tenca A, Pugliese D, Consonni D et al. Bleeding after sphincterotomy in liver transplanted patients with biliary complications. Eur J Gastroenterol Hepatol. 2011 Sep;23(9):778-81. doi: 10.1097/MEG.0b013e32834928e8.
54. García-Pajares F, Sánchez-Antolín G, Pelayo S.L et al. Transplantation Proceedings 2010, 42, 2966–2969
55. Navaneethan U, Jegadeesan R, Nayak Set al. ERCP-related adverse events in patients with primary sclerosing cholangitis. Gastrointest Endosc.2014 Jul 30. pii: S0016-5107(14)01878-1. doi: 10.1016/j.gie.2014.06.030
56. Yamamoto N, Isayama H, Sasahira N et al. Endoscopic minor papilla balloon dilation for the treatment of symptomatic pancreas divisum. Pancreas. 2014 Aug;43(6):927-30. doi: 10.1097/MPA.0000000000000148
57. Moffatt DC, Coté GA, Avula H et al. Risk factors for ERCP-related complications in patients with pancreas divisum: a retrospective study. Gastrointest Endosc. 2011 May;73(5):963-70. doi: 10.1016/j.gie.2010.12.035. Epub 2011 Mar 9
58. Artifon EL, da Silveira EB, Aparicio D et al. Management of common bile duct stones in cirrhotic patients with coagulopathy: a comparison of supra-papillary puncture and standard cannulation technique. Dig Dis Sci. 2011 Jun;56(6):1904-11. doi: 10.1007/s10620-011-1593-2. Epub 2011 Feb 12
59. Yun DY, Han J, Oh JS et al. Is endoscopic retrograde cholangiopancreatography safe in patients 90 years of age and older? Gut Liver. 2014 Sep;8(5):552-6. doi: 10.5009/gnl13310. Epub 2014 Feb 24)
60. Troendle DM, Barth BA. ERCP can be safely and effectively performed by a pediatric gastroenterologist for choledocholithiasis in a pediatric facility.J Pediatr Gastroenterol Nutr. 2013 Nov;57(5):655-8. doi: 10.1097/MPG.0000000000000124
61. Lü T, Zhang XF. [Analysis of clinical application of endoscopic retrograde cholangiopancreatography for the pancreatic diseases in children]. Zhonghua Er Ke Za Zhi. 2013 May;51(5):367-70
62. Cerezo-Ruiz A , Casáis-Juanena LL , Naranjo-Rodríguez A et al. Colangiopancreatografía retrógrada endoscópica en pacientes menores de 18 años: nuestra experiencia. Gastroenterología y Hepatología 2008;31(08): 490-493 )
63. Hori Y, Naitoh I, Nakazawa T et al. Feasibility of endoscopic retrograde cholangiopancreatography-related procedures in hemodialysis patients. J Gastroenterol Hepatol.2014 Mar;29(3):648-52. doi: 10.1111/jgh.12336)
64. Takahara N, Isayama H, Sasaki T et al. Endoscopic papillary balloon dilation for bile duct stones in patients on hemodialysis. J Gastroenterol. 2012 Aug;47(8):918-23. doi: 10.1007/s00535-012-0551-x. Epub 2012 Feb 22
65. Matsushita M, Takakuwa H, Shimeno N et al. Prophylactic injection of hypertonic saline-epinephrine oral to the papilla for prevention of postsphincterotomy bleeding. .J Clin Gastroenterol. 2010 Sep;44(8):e167-70. doi: 10.1097/MCG.0b013e3181e5ceca
66. Hui CK, Lai KC, Yuen MF et al. Does withholding aspirrin for one week reduce the risk of post-sphinsterotomy bleeding? Aliment Pharmacol Ther 2002;16:929-936
67. Nelson DB, Freeman ML: Mayor haemorrhage from endoscopio sphincterotomy: risk factor análisis. J Clin Gastroenterol 1994;19:283-287
68. Onal IK, Parlak E, Akdogan M et al. Do aspirin and non-steroidal anti-inflammatory drugs increase the risk of post-sphincterotomy hemorrhage -a case-control study. Clin Res Hepatol Gastroenterol.2013 Apr;37(2):171-6. doi: 10.1016/j.clinre.2012.04.010. Epub 2012 Jun 5
69. Patai A, Solymosi N, Patai AV. Does Rectal Indomethacin Given for Prevention of Post-ERCP Pancreatitis Increase Bleeding After Biliary Endoscopic Sphincterotomy or Cardiovascular Mortality?: Post Hoc Analysis Using Prospective Clinical Trial Data. Medicine (Baltimore).2014 Nov;93(26):e159. doi: 10.1097/MD.000000000000015
70. Rustagi T,Jamidar PA. Endoscopic Retrograde Cholangiopancreatography-Related Adverse Events: General Overview. Gastrointest Endosc Clin N Am.2015 Jan;25(1):97-106. doi: 10.1016/j.giec.2014.09.005
71. Koh HR, Park CH, Chung MW et al. Endoscopic retrograde cholangiopancreatography in patients with previous acute coronary syndrome. Gut Liver.2014 Nov;8(6):674-9. doi: 10.5009/gnl13301. Epub 2014 Nov 15)
72. Lee MG, Kim J, Lee SH et al. Effect of sustained use of platelet aggregation inhibitors on post-endoscopic sphincterotomy bleeding. Dig Endosc.2014 Nov;26(6):737-44. doi: 10.1111/den.12271. Epub 2014 Mar 27).
73. Abdel Samie A A, Sun R, Vöhringer U et al. Safety of endoscopic sphincterotomy in patients under dual antiplatelet therapy. Hepatogastroenterology.2013 Jun;60(124):659-61. doi: 10.5754/hge12356. Epub 2012 Dec 28
74. Hussain N, Alsulaiman R, Burtin P et al. The safety of endoscopic sphincterotomy in patients receiving antiplatelet agents: a case-control study. Aliment Pharmacol Ther 2007;25:579-584
75. Boustière C, Veitch A, Vanbiervliet G et al. ESGE Guideline: Endoscopy and antiplatelet agents. Endoscopy 2011; 43: 445–458
76. Zuckerman, MJ, Hirota, WK, Adler, DG et al. ASGE guideline: the management of low-molecular-weight heparin and nonaspirin antiplatelet agents for endoscopic procedures. Gastrointest Endosc 2005; 61 (2):189-194
77. Alberca-de-las-Parras F. Clinical practice guidelines for managing coagulation in patients undergoing endoscopic procedures. Rev Esp Enferm Dig 2010; 102(2):124-138
78. Veitch AM, Baglin TP, Gershlick AH et al. Guidelines for the management of anticoagulant endoscopic procedures and antiplatelet therapy in patients undergoing endoscopic procedures. Gut 2008;57;1322-1329
79. Becker RC, Scheiman J, Dauerman HL et al; American College of Cardiology and the American College of Gastroenterology. Management of platelet‑directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. Am J Gastroenterol. 2009; 104: 2903-2917
80. Alberca de las Parras F, Marín F, Roldán Schilling V et al. Manejo de los fármacos antitrombóticos asociados a los procedimientos endoscópicos. Rev Esp Enferm Dig 2015;107:289-306
81. Hittelet A, Devière J. Management of anticoagulants before and after endoscopy. Can J Gastroenterol.2003 May;17(5):329-32
82. Rabenstein T, Schneider HT, Bulling D et al. Analysis of the risk factors associated with endoscopic sphincterotomy techniques: preliminary results of a prospective study, with emphasis on the reduced risk of acute pancreatitis with low-dose anticoagulation treatment. Endoscopy. 2000 Jan;32(1):10-9
83. Oren A, Breumelhof R, Timmer R et al. Abnormal clotting parameters before therapeutic ERCP: do they predict major bleeding? Eur J Gastroenterol Hepatol. 1999 Oct;11(10):1093-7
84. Ross I Baker, Paul B Coaughlin, Alex S Gallus et al; the Warfarin Reversal Consensos Group. Warfarin reversal: consensos guidelines, on behalf of the Australasian Society of Trombosis and Haemostasis. Medical Journal of Australia 2004; 181 (9): 492-497
3. OCEBM Levels of Evidence Working Group*. The Oxford Levels of Evidence 2″.Oxford Centre for Evidence-Based Medicine.http://www.cebm.net/index.aspx?o=5653)
85. Acosta, Ruben D, Abraham, Neena S, Chandrasekhara, Vinay et al. The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc 2016; 83:3–16
86. Siegal D, Yudin J, Kaatz S, et al. Periprocedural heparin bridging in patients receiving vitamin K antagonists. Circulation 2012;126:1630-9.